Click for best price
Meniere's Disease Drugs Market Size, Share 2022
Meniere?s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere?s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease but different treatments can help in minimizing the symptoms.
This report contains market size and forecasts of Meniere's Disease Drugs in Global, including the following market information:
Global Meniere's Disease Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Meniere's Disease Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Motion Sickness Medication Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Meniere's Disease Drugs include Roche, Novartis, Pfizer, Auris Medical, Jubilant Cadista, Otonomy, Sound Pharmaceuticals and WellSpring Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Meniere's Disease Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Meniere's Disease Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Meniere's Disease Drugs Market Segment Percentages, by Type, 2021 (%)
Motion Sickness Medication
Anti-Nausea Medication
Others
Global Meniere's Disease Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Meniere's Disease Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Medical Research Centers
Others
Global Meniere's Disease Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Meniere's Disease Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Meniere's Disease Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Meniere's Disease Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Pfizer
Auris Medical
Jubilant Cadista
Otonomy
Sound Pharmaceuticals
WellSpring Pharmaceutical
| Report Attributes |
Report Details |
| Report Title |
Meniere's Disease Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Meniere's Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Meniere's Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Meniere's Disease Drugs Overall Market Size
2.1 Global Meniere's Disease Drugs Market Size: 2021 VS 2028
2.2 Global Meniere's Disease Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Meniere's Disease Drugs Players in Global Market
3.2 Top Global Meniere's Disease Drugs Companies Ranked by Revenue
3.3 Global Meniere's Disease Drugs Revenue by Companies
3.4 Top 3 and Top 5 Meniere's Disease Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Meniere's Disease Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Meniere's Disease Drugs Players in Global Market
3.6.1 List of Global Tier 1 Meniere's Disease Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Meniere's Disease Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Meniere's Disease Drugs Market Size Markets, 2021 & 2028
4.1.2 Motion Sickness Medication
4.1.3 Anti-Nausea Medication
4.1.4 Others
4.2 By Type - Global Meniere's Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Meniere's Disease Drugs Revenue, 2017-2022
4.2.2 By Type - Global Meniere's Disease Drugs Revenue, 2023-2028
4.2.3 By Type - Global Meniere's Disease Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Meniere's Disease Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Medical Research Centers
5.1.5 Others
5.2 By Application - Global Meniere's Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Meniere's Disease Drugs Revenue, 2017-2022
5.2.2 By Application - Global Meniere's Disease Drugs Revenue, 2023-2028
5.2.3 By Application - Global Meniere's Disease Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Meniere's Disease Drugs Market Size, 2021 & 2028
6.2 By Region - Global Meniere's Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Meniere's Disease Drugs Revenue, 2017-2022
6.2.2 By Region - Global Meniere's Disease Drugs Revenue, 2023-2028
6.2.3 By Region - Global Meniere's Disease Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Meniere's Disease Drugs Revenue, 2017-2028
6.3.2 US Meniere's Disease Drugs Market Size, 2017-2028
6.3.3 Canada Meniere's Disease Drugs Market Size, 2017-2028
6.3.4 Mexico Meniere's Disease Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Meniere's Disease Drugs Revenue, 2017-2028
6.4.2 Germany Meniere's Disease Drugs Market Size, 2017-2028
6.4.3 France Meniere's Disease Drugs Market Size, 2017-2028
6.4.4 U.K. Meniere's Disease Drugs Market Size, 2017-2028
6.4.5 Italy Meniere's Disease Drugs Market Size, 2017-2028
6.4.6 Russia Meniere's Disease Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Meniere's Disease Drugs Market Size, 2017-2028
6.4.8 Benelux Meniere's Disease Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Meniere's Disease Drugs Revenue, 2017-2028
6.5.2 China Meniere's Disease Drugs Market Size, 2017-2028
6.5.3 Japan Meniere's Disease Drugs Market Size, 2017-2028
6.5.4 South Korea Meniere's Disease Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Meniere's Disease Drugs Market Size, 2017-2028
6.5.6 India Meniere's Disease Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Meniere's Disease Drugs Revenue, 2017-2028
6.6.2 Brazil Meniere's Disease Drugs Market Size, 2017-2028
6.6.3 Argentina Meniere's Disease Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Meniere's Disease Drugs Revenue, 2017-2028
6.7.2 Turkey Meniere's Disease Drugs Market Size, 2017-2028
6.7.3 Israel Meniere's Disease Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Meniere's Disease Drugs Market Size, 2017-2028
6.7.5 UAE Meniere's Disease Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Meniere's Disease Drugs Major Product Offerings
7.1.4 Roche Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.1.5 Roche Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Meniere's Disease Drugs Major Product Offerings
7.2.4 Novartis Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.2.5 Novartis Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Meniere's Disease Drugs Major Product Offerings
7.3.4 Pfizer Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.3.5 Pfizer Key News
7.4 Auris Medical
7.4.1 Auris Medical Corporate Summary
7.4.2 Auris Medical Business Overview
7.4.3 Auris Medical Meniere's Disease Drugs Major Product Offerings
7.4.4 Auris Medical Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.4.5 Auris Medical Key News
7.5 Jubilant Cadista
7.5.1 Jubilant Cadista Corporate Summary
7.5.2 Jubilant Cadista Business Overview
7.5.3 Jubilant Cadista Meniere's Disease Drugs Major Product Offerings
7.5.4 Jubilant Cadista Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.5.5 Jubilant Cadista Key News
7.6 Otonomy
7.6.1 Otonomy Corporate Summary
7.6.2 Otonomy Business Overview
7.6.3 Otonomy Meniere's Disease Drugs Major Product Offerings
7.6.4 Otonomy Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.6.5 Otonomy Key News
7.7 Sound Pharmaceuticals
7.7.1 Sound Pharmaceuticals Corporate Summary
7.7.2 Sound Pharmaceuticals Business Overview
7.7.3 Sound Pharmaceuticals Meniere's Disease Drugs Major Product Offerings
7.7.4 Sound Pharmaceuticals Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.7.5 Sound Pharmaceuticals Key News
7.8 WellSpring Pharmaceutical
7.8.1 WellSpring Pharmaceutical Corporate Summary
7.8.2 WellSpring Pharmaceutical Business Overview
7.8.3 WellSpring Pharmaceutical Meniere's Disease Drugs Major Product Offerings
7.8.4 WellSpring Pharmaceutical Meniere's Disease Drugs Revenue in Global Market (2017-2022)
7.8.5 WellSpring Pharmaceutical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Meniere's Disease Drugs Market Opportunities & Trends in Global Market
Table 2. Meniere's Disease Drugs Market Drivers in Global Market
Table 3. Meniere's Disease Drugs Market Restraints in Global Market
Table 4. Key Players of Meniere's Disease Drugs in Global Market
Table 5. Top Meniere's Disease Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Meniere's Disease Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Meniere's Disease Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Meniere's Disease Drugs Product Type
Table 9. List of Global Tier 1 Meniere's Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Meniere's Disease Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Meniere's Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Meniere's Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Meniere's Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Meniere's Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Meniere's Disease Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Meniere's Disease Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Meniere's Disease Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Meniere's Disease Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Meniere's Disease Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Meniere's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Meniere's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Meniere's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Meniere's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Meniere's Disease Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Roche Corporate Summary
Table 31. Roche Meniere's Disease Drugs Product Offerings
Table 32. Roche Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Meniere's Disease Drugs Product Offerings
Table 35. Novartis Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer Corporate Summary
Table 37. Pfizer Meniere's Disease Drugs Product Offerings
Table 38. Pfizer Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Auris Medical Corporate Summary
Table 40. Auris Medical Meniere's Disease Drugs Product Offerings
Table 41. Auris Medical Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Jubilant Cadista Corporate Summary
Table 43. Jubilant Cadista Meniere's Disease Drugs Product Offerings
Table 44. Jubilant Cadista Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Otonomy Corporate Summary
Table 46. Otonomy Meniere's Disease Drugs Product Offerings
Table 47. Otonomy Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Sound Pharmaceuticals Corporate Summary
Table 49. Sound Pharmaceuticals Meniere's Disease Drugs Product Offerings
Table 50. Sound Pharmaceuticals Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
Table 51. WellSpring Pharmaceutical Corporate Summary
Table 52. WellSpring Pharmaceutical Meniere's Disease Drugs Product Offerings
Table 53. WellSpring Pharmaceutical Meniere's Disease Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Meniere's Disease Drugs Segment by Type in 2021
Figure 2. Meniere's Disease Drugs Segment by Application in 2021
Figure 3. Global Meniere's Disease Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Meniere's Disease Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Meniere's Disease Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Meniere's Disease Drugs Revenue in 2021
Figure 8. By Type - Global Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 12. US Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 24. China Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Meniere's Disease Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Meniere's Disease Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Roche Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Auris Medical Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Jubilant Cadista Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Otonomy Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sound Pharmaceuticals Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. WellSpring Pharmaceutical Meniere's Disease Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
